Cell intrinsic and extrinsic mechanisms of stem cell aging depend on telomere status.
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The function of adult stem cells declines during aging and chronic diseases. An understanding of the molecular mechanisms underlying these processes will help to identify targets for future therapies in order to improve regenerative reserve and organ maintenance. Telomere shortening represents a cell intrinsic mechanism inducing DNA damage in aging cells. Current studies in telomerase knockout mice have shown that telomere dysfunction induces cell intrinsic checkpoints and environmental alteration that limit stem cell function. While these phenotypes differ from wildtype mice with long telomere reserves, they appear to be relevant for human aging, which is associated with an accumulation of telomere dysfunction and DNA damage.
Introduction
There is growing evidence for a functional decline of adult stem cells during aging. In aging mammals, the functional reserve of adult stem cells decreases in the hematopoietic system (Waterstrat et al., 2008.) , in pancreatic islets , in areas of neurogenesis in the brain (Molofsky et al., 2006) , in hair follicles (Nishimura et al., 2005) , in intestinal crypts (Martin et al., 1998) , and in muscle (Brack and Rando, 2007) .
Several lines of evidence indicate that the decline in stem cell function during aging can involve both cell intrinsic mechanisms and environmental alterations [for review see: ]. In humans, it has been shown that both donor age (Castro-Malaspina et al., 2002; Kollman et al., 2001) and recipient age (Kantarjian et al., 2006; Socie et al., 1999) influence patients' outcomes in response to hematopoietic stem cell (HSC) transplantation. These clinical data indicate that cell intrinsic and cell extrinsic (environmental) mechanisms could contribute to the functional decline of HSCs during human aging. The relative contribution of these mechanisms to the decline in function and maintenance of aging stem cells remains to be defined in different organ systems and genetic modifiers have yet to be identified. Overcoming these obstacles may provide a rational basis to begin therapeutic strategy development, which could improve regenerative reserve during aging. In this review, we focus on the influence of telomere dysfunction on cell intrinsic and cell extrinsic mechanisms limiting stem cell function during aging.
Telomere shortening and cellular aging
Telomeres consist of simple tandem DNA repeats and associated telomere binding proteins (de Lange, 2005) . The main function of telomeres is to cap chromosome ends thus preventing an activation of DNA damage responses and the evolution of chromosomal instability (Blackburn, 2001) . Telomeres shorten with each round of cell division due to the 'end replication problem' of DNA polymerase and due to processing of telomeres during cell cycle (Levy et al., 1992; Sfeir et al., 2005) . The enzyme telomerase is required to compensate for telomere shortening. Telomerase synthesizes telomeres de novo. In humans, telomerase is active during embryogenesis (Wright et al., 1996) , but it is suppressed in most somatic cells after birth. In adults, telomerase remains active in germ cells and certain stem cell compartments, like in intestinal stem cells and 3 hematopoietic stem cells (Broccoli et al., 1995, for review see: Martens, 2005, Artandi, 2008) . In addition, telomerase is transiently up-regulated in stimulated lymphocytes (Hiyama et al., 1995) . Telomere shortening limits the lifespan of primary human cells to a finite number of cell divisions, which is 50-70 for human fibroblast. This limit is called after the discoverer -the 'Hayflick limit' (Hayflick, 1965) . Studies on over-expression of telomerase have proven that telomere shortening is the underlying mechanism limiting the lifespan of human cells (Bodnar et al., 1998) . Since most primary human cells lack telomerase expression the lifespan of human cells is limited by telomere shortening. Studies on human fibroblasts have shown that telomere shortening induces two checkpoints. The first checkpoint is activated in response to low levels of telomere dysfunction [3-5 dysfunctional telomeres per cell, (Zou et al., 2004) ]. At this stage human fibroblasts enter a permanent cell cycle arrest, which is called replicative senescence (Wright and Shay, 1992) . Human fibroblasts can escape the senescence checkpoint when p53 and Rb checkpoints are abrogated (Wright and Shay, 1992) . However, during this extended lifespan period (ca. 10-20 cell divisions) telomeres continue to shorten and eventually reach a second checkpoint, which is called crisis (Wright and Shay, 1992) . Crisis is characterized by high levels of telomere dysfunction, massive chromosomal instability, and cell death.
Telomere shortening and human aging
There is ample evidence that telomeres shorten during human aging . This shortening also affects stem cell compartments, e.g., telomeres shorten in CD34+ hematopoietic cells during human aging (Vaziri et al., 1994) , although human HSCs exhibit low level of telomerase activity. Together, it appears that telomerase expression contributes to the proliferative capacity of human HSCs but the level of telomerase expression is not sufficient to maintain stable telomeres into old age (Zimmermann and Martens, 2005) .
In addition to telomere shortening during aging, various chronic diseases accelerate telomere shortening in humans . This has been reported for different forms of anemia, hypertension, coronary heart diseases, chronic HIV infection, ulcerative colitis, chronic liver disease, and others (Wiemann et al., 2002 ). Moreover, telomere shortening during chronic diseases is often associated with disease progression , Wiemann et al., 2002 . It has also been documented that telomere shortening correlates with age-related pathology and reduced human lifespan (Cawthon et al., 2003; Collerton et al., 2007) . Lastly, mutations in human telomerase genes lead to telomere shortening, stem cell defects, impaired organ maintenance and a shortened lifespan (Armanios et al., 2007; Tsakiri et al., 2007; Vulliamy et al., 2004) . Together, these data strongly indicate that human telomere reserves are limited. New experimental data indicate that increasing levels of biomarkers of telomere dysfunction and DNA damage characterize human aging and aging-associated disease (Jiang et al. 2008) . Given the pivotal role of telomeres and adult stem cells for tissues maintenance and repair, it appears to be of utmost importance to understand the functional consequences of telomere dysfunction on stem cell levels. The characterization of stem cell aging in wild type mice cannot address this critical question since laboratory wild type mouse strains have very long telomeres compared to humans 4 (Prowse and Greider, 1995) and inbred laboratory wildtype mice do not experience significant levels of telomere dysfunction during aging (Jiang et al. 2008) . In fact, there is experimental evidence that the decline in stem cell function in wild type laboratory mouse strains is mainly driven by telomere-independent mechanisms (Allsopp et al., 2003) .
DNA damage signalling in response to telomere dysfunction
Critical telomere shortening leads to uncapping of chromosomal ends. These dysfunctional telomeric ends are recognized as DNA double strand breaks, that lead to activation of DNA-damage checkpoints (d' Adda di Fagagna et al., 2003; Takai et al., 2003) . DNA damage signals in response to telomere dysfunction are similar to those induced by γ-irradiation. The initial step of this DNA damage signalling is the formation of DNA damage foci at dysfunctional telomeres. These foci consist of proteins involved in DNA damage recognition and repair including γH2AX, 53bp1, NBS1, MDC1, among others (d' Adda di Fagagna et al., 2003; Satyanarayana et al., 2004) . These DNA damage foci induce ATM/Chk2 and ATR/Chk1 kinase pathways (d' Adda di Fagagna et al., 2003) activating p53 (Gire et al., 2004 , Chin et al., 1999 and its downstream target p21 (Brown et al., 1997) inducing cellular senescence (Brown et al., 1997) . In contrast to the senescence checkpoint, the crisis checkpoint is less well understood and may involve an activation of multiple p53-independent checkpoints inducing cell death.
There is a continuous need to investigate checkpoints in response to telomere dysfunction using in vivo models. It is conceivable that telomere dysfunction induces different checkpoint responses depending on the tissue type. In addition, checkpoint responses in stem cells may differ from somatic cells. In line with this assumption, it has been shown that embryonic stem cells lack efficient G1 cell cycle checkpoints in response to γ-irradiation (Hong and Stambrook, 2004) . It is currently unknown whether similar differences are present in adult stem cells compared to somatic cells. Given the difficulties in culturing undifferentiated, adult stem cells, it is necessary to investigate consequences of telomere dysfunction using in vivo models.
Telomere shortening and stem cell aging
Inbred laboratory mice have long telomeres (25 -60 kb compared to 10-12 kb in humans) and a short lifespan (24-30 months) compared to 75-80 years in humans (Cawthon et al., 2003; Choudhury et al., 2007; Prowse and Greider, 1995) . Using an unbiased proteomic approach we have recently identified biomarkers of telomere dysfunction. These markers show an increased expression in various tissues and blood plasma of aging telomere dysfunctional mice but not in wildtype controls. The same biomarkers significantly increase during human aging and aging-associated disease (Jiang et al. 2008) . Together these results support the hypothesis that accumulation of telomere dysfunction and DNA damage contribute to human aging, but have little impact on aging of wild type mice with long telomere reserves. Thus, telomerase knockout mice provide a unique experimental model to study the in vivo consequences of this important aspect of human aging.
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Current experimental evidence indicates that telomere shortening influences stem cell aging. In some wild type mouse strains (e.g., C57Bl/6J) the number of HSCs increases during aging, whereas other mouse strains, such as DAB2 and BalbC, show a decrease in HSC number during aging (Morrison et al., 1996 , Waterstrat et al., 2008 . Interestingly, the number of HSCs has been associated with murine lifespan (Henckaerts et al., 2004; Van Zant et al., 1990) . Although HSCs in wildtype C57Bl/6J mice acquire defects in long-term repopulating potential during aging, the total stem cell activity remains fairly constant due to the increase in stem cell number in this strain . Moreover, C57BL/6J mice rarely develop hematopoietic failure during aging. This scenario appears to be very different from human aging, which is characterized by a decline in HSC number (Waterstrat et al.,2008) , and frequent occurrence of bone marrow failure and anemia (Beghe et al., 2004 ). It appears likely that shorter telomeres and longer lifespan in humans represent fundamental differences affecting stem cell aging in humans but not in C57BL/6J mice. In agreement with this assumption, heterozygous mutations in telomerase gene impair telomerase activity by haplo-insufficiency and represent risk factors for bone marrow failure in human aplastic anemia and dyskeratosis congenita (DC) (Vulliyami et al., 2004) . In contrast, heterozygous mutations of telomerase in C57BL/6J mice with long telomeres have little effect on stem cell function during aging . However, the heterozygous deletion of telomerase in a mouse strain with short telomeres (CAST/EjI) induced stem cell defects and impairment of organ maintenance similar to the human situation (Hao et al., 2005) . Together, these results indicate that laboratory mouse strains with long telomeres lack telomere shortening, which represent one important aspect of human aging.
Studies on telomerase knockout mice (Terc-/-) have provided first experimental evidence that telomere shorting has a causal role in limiting organ maintenance and lifespan (Rudolph et al., 1999) . Terc-/-mice with short telomeres showed premature aging phenotypes, specifically affecting organ systems with high rate of cell turnover Lee et al., 1998) . Aging phenotypes of hematopoietic stem cells in Terc-/-mice are different from HSC aging in wild type mice (Table 1) . Given the prevalence of telomere shortening in human aging (see above) studies on Terc-/-mice may allow a better understanding of telomere dependent mechanisms of stem cell aging in humans.
In contrast to wild type C57BL/6J mice (see above), the number of long-term HSCs does not significantly expand in aging Terc-/-C57BL/6J mice with dysfunctional telomeres, but rather shows a decrease compared to age-matched wildtype controls . Moreover, Terc-/-mice more frequently develop hematopoietic failure, which also occurs during human aging, namely anemia and a reduction in lymphocytes and total white blood counts (Rudolph et al., 1999) . In addition, telomere dysfunction impaired the function of HSCs in transplantation experiments (see below). In addition to the defects in the hematopoietic system, telomere dysfunctional mice exhibited a stem cell depletion phenotype affecting germ cells, intestinal stem cells, and neuronal stem cells Wong et al., 2003) . Together, these findings suggest that adult stem cells are the most sensitive cell compartment affected by telomere dysfunction.
In human, two important pathophysiological features of the aged hematopoietic system are a 6 decrease in lymphopoiesis and immune function and an increase in myeloproliferative disease. Evidence from humans HSC transplantation (see above) and mice experiments (see below) indicate that stem cell intrinsic and extrinsic mechanisms contribute to the age-dependent decline in stem cell function. In wild type mice, a similar skewing of hematopoiesis (decreased lymphoiesis, increased myelopoiesis) occurs during aging. This phenotype in wild type mice is transplantable and is characterised by cell intrinsic changes in gene expression suggesting that this phenotype can be induced by cell intrinsic mechanisms Rossi et al., 2005) . However, there is also evidence that cell extrinsic alteration may contribute to impaired b-lymphopoiesis in aging wild type mice (Labrie et al., 2004; Stephan et al., 1998) . Moreover, it was shown that the aging environment impairs the homing of transplanted HSCs (Liang et al., 2005) . In aging telomere dysfunctional Terc-/-C57BL/6J mice, the skewing of hematopoiesis is accelerated compared to wild type mice . Interestingly, the skewing of hemato-lymphopoiesis in Terc-/-mice is mainly induced by cell extrinsic alterations, whereas stem cell intrinsic checkpoints affect self-renewal and repopulation capacity of telomere dysfunctional HSCs .
Given the evidence for a functional role of telomere dysfunction during human aging (see above) the following section will provide a summary of cell intrinsic and extrinsic alterations that limit stem cell function in response to telomere dysfunction.
Cell intrinsic checkpoints limiting stem cell function in response to telomere dysfunction
Experiments in late generation mTerc-/-mice revealed first experimental evidence that cell intrinsic checkpoints contribute to the decline in stem cell function in response to telomere dysfunction and aging. Comparing studies on wild type and telomerase knockout mice it becomes clear that DNA damage checkpoint genes can have protective or detrimental effects on stem cell function depending on telomere status (Table 2 ). (i) Exonuclease-1 (Exo1): Exo1 is a 5-3 prime exonuclease involved in the DNA mismatch repair pathway (Amin et al., 2001) . Exo1 deletion rescued the induction of senescence in response to telomere dysfunction in yeast cells (Bertuch and Lundblad, 2004; Hackett and Greider, 2003; Maringele and Lydall, 2004) . In Terc-/-mice, Exo1 deletion improved the maintenance of intestinal stem cells and rescued the skewing of hemato-/lymphopoiesis in aging telomere dysfunctional mice. The study revealed that Exo1 deletion prevented the formation of single stranded DNA and the activation of ATR-p53-p21 signaling pathway . This rescue in DNA damage signaling was associated with improved cell cycle activity and reduced induction of apoptosis in intestinal stem and progenitor cells in response to telomere dysfunction. Studies on PMS2 have also shown a role of mismatch repair in DNA damage signaling in response to telomere dysfunction (Siegl-Cachedenier et al., 2007) . In contrast to the rescue of intestinal stem cells in response to deletion of mismatch repair genes in telomere dysfunctional mice, the deletion of the mismatch repair gene MSH2 diminished the function of HSCs in wild tpe mice (Reese et al., 2003) . (ii) Ataxia Telangiectasia Mutated (ATM): Deletion of ATM did not rescue the activation of 7 p53-signalling in telomere dysfunctional mice indicating that ATM-independent pathways can activate p53 in response to telomere dysfunction . Paradoxically the deletion of ATM enhanced aging phenotypes in mTERC -/mice . A potential explanation is that ATM itself has a role in telomere capping and ATM deletion may increase telomere dysfunction (Bi et al., 2004) . In addition, ATM plays a crucial role in reactive oxygen species (ROS) metabolism and the increase in ROS level in ATM-/-cells may cooperate with telomere dysfunction to aggravate aging phenotypes. Indeed, ATM deficiency affected the function of HSCs in wild type mice with long telomeres (Ito et al., 2004) . However, these defects only occurred in response to stress and not under homeostatic conditions in aging mice. Moreover, the effects of ATM mutations in humans (e.g. impaired organ homeostasis including neurodegeneration, immunodeficiency, and predisposition to malignancy) were not fully reproduced in mTerc +/+ mice with long telomere but to a greater extent in telomere dysfunctional mice . These data suggest that telomere shortening can cooperate with other genetic lesions to induce aging related pathology. In line with this assumption, Wrn knockout mice with long telomere reserves did not display typical cellular or clinical phenotypes of human Werner syndrome (Lombard et al., 2000) . However, in late generation Terc -/mice, deletion of Wrn accelerated the overall attrition of telomere length, resulting in phenotypes resembling human Werner syndrome, including early onset of age-related disorders, increased incidence of mesenchymal cancers, and premature death (Chang et al., 2004; Du et al., 2004) . (iii) p53: p53 appears to have a more complicated role in stem cell aging. First, in Terc +/+ mice, p53 seems to have a dose effect on organismal aging and stem cell function. Mice with a hypermorphic form of p53 showed reduced longevity, osteoporosis, generalized organ atrophy, and impaired stress tolerance (Tyner et al., 2002) . Moreover, overactive p53 decreased the number and function of HSCs, whereas heterozygous deletion of p53 increased proliferation of HSCs during mouse aging (Dumble et al., 2007) . In contrast, mice containing an extra copy of naturally regulated p53 and p19ARF(under control of the natural promoters of these genes) did not show increased tissue atrophy but an elongated lifespan (Matheu et al., 2007) . The authors proposed that naturally regulated p53 is preferentially activated in damaged cells thus protecting the organisms from an accumulation of damaged cells. However, introducing an extra copy of p53 did not improve the lifespan of Terc-/-mice, although the load of damaged cells is higher in the context of telomere dysfunction in Terc-/-mice compared to wild type mice (Garcia-Cao et al., 2006) . A possible explanation for this difference could be that an extra copy of p53 can only delay aging in a context of relatively mild accumulation of DNA and telomeric damage. In contrast, in the context of high levels of DNA or telomeric damage beneficial effects of higher checkpoint control may be counteracted by the fact that the number of surviving cells falls under a critical threshold. The consequences of increased activity of naturally regulated p53 on human aging remain speculative. The above discussed similarities between human aging and aging of telomere dysfunctional mice suggest that increased activity of p53 may not improve organismal fitness. (iv) p21: Deletion of p21 improved organ homeostasis and elongated lifespan of telomere dysfunctional mice without accelerating cancer formation . A possible explanation is that apoptosis checkpoints remained intact preventing an increase in chromosomal instability and cancer formation. Interestingly, deletion of p21 improved self renewal and repopulation capacity of HSCs in aging telomere dysfunctional mice , but impaired stem cell maintenance and repopulation capacity of HSCs in wildtype mice (Cheng et al., 2000) . However, the latter effect appears to show mouse strain specificity and may only be relevant in the context of replication stress (van Os et al., 2007) . Together, p21 could have a dual role in aging stem cells . In non-damaged stem cells of wildtype mice, p21 contributes to the maintenance of stem cell quiescence thus preventing abnormal cycling and stem cell depletion. In contrast, p21 impairs self renewal and function of stem cells accumulating telomere dysfunction. (v) p16/p19: Experiments in wild type mice showed that p16-deletion improved regenerative capacity in different stem cell compartments including HSCs, neuronal stem cells, and pancreatic islets. These data indicate that p16 might be one of the causal factors limiting stem cell function in aging wild type mice with long telomere reserves (Janzen et al., 2006; Krishnamurthy et al., 2006; Molofsky et al., 2006) . In line with this hypothesis, expression of Bmi-1 (a repressor of p16) promotes stem cell self-renewal in wildtype mice (Hosen et al., 2007) . In contrast to aging of wild type mice, p16 and p19ARF deletion did not improve organ maintenance and lifespan of telomere dysfunctional mice indicating that this pathway is not a major component limiting stem cell function in response to telomere dysfunction (Khoo et al., 2007) .
Together the above studies show that cell intrinsic DNA damage checkpoints have very different effects on stem cell aging depending on the telomere status.
Cell extrinsic checkpoints limiting stem cell function in response to telomere dysfunction
Cell extrinsic mechanisms contribute to the decline in stem cell function in aging mice (Liang et al. 2005 , Stephan et al. 1998 , Labrie et al. 2004 . Telomere dysfunction increased the influence of environmental alterations limiting the function of HSCs in aging mice. Experimental evidence for an accumulation of telomere dysfunction in aging humans (Jiang et al. 2008 ) and clinical data (Table 1) support the hypothesis that environmental alterations induced by telomere dysfunction could contribute to the decline in stem cell function in human aging.
One hallmarks of HSC aging is the skewing of hemato-/lymphopoiesis (decreased lymphopoiesis and increased myelopoiesis) occurring during human and mouse aging (Kim et al., 2003; Morrison et al., 1996; Rossi et al., 2005; Sudo et al., 2000) . The skewing of hemato-/lymphopoiesis occurs in aging wild type mice and in Terc-/-mice with dysfunctional telomeres (Rossi et al., 2005; Rudolph et al., 1999; . However, in Terc-/-mice, the phenotype is accelerated and appears earlier in life compared to wild type mice . Experimental data suggest that skewing of hemato-lymphopoiesis in aging wild type mice is induced by both cell-intrinsic and cell extrinsic mechanisms (see above and Labrie et al., 2004; Rossi et al., 2005; Stephan et al., 1998) . In contrast, the skewing of hemato-/lymphopoiesis in aging mTerc-/-mice with dysfunctional telomeres was mainly due to cell extrinsic mechanisms. Skewing of hemato-lymphopoiesis was rescued when Terc-/-HSCs were transplanted into a 9 wildtype environment. Moreover, young wildtype HSC showed skewing when transplanted into telomere dysfunctional recipients . Together, these results indicate that telomere dysfunction increases the influence of cell extrinsic factors on stem cell aging (Table 1) .
The defects of the stem cell environment in telomere dysfunctional mice were age-dependent and correlated with progressive telomere shortening in bone marrow stromal cells ). Telomere dysfunctional mice showed an impaired capacity of bone marrow stromal cells to maintain functional HSCs, and an increased expression of various cytokines, including granulocyte colony-stimulating factor (G-CSF) in blood serum and in supernatant of primary bone marrow stromal cells. Administration of G-CSF to wild-type mice mimicked some of the defects seen in aging telomere dysfunction mice, including impairment of b-lymphopoiesis and HSC engraftment. Conversely, inhibition of G-CSF improved HSC engraftment in aged telomere dysfunction mice.
Proteomic analysis on cell extrinsic proteins in culture supernatant of bone marrow from telomere dysfunctional mice has identified a new set of biomarker showing increased expression in response to telomere dysfunction in aging mTerc-/-mice (Jiang et al. 2008) . Interestingly, these biomarkers showed increased expression in human cells in response to telomere dysfunction and irradiation induced DAN damage. Moreover, the expression levels of these proteins in blood serum were robust indicators for human aging and age related diseases indicating that similar cell extrinsic alterations occur in aging humans and telomere dysfunctional mice.
There is accumulating evidence that cell extrinsic alterations contribute to the decline in stem cell function in various organ systems during aging (Conboy et al., 2005; Ryu et al., 2006, Mackall and Gress, 1997; , Collins et al.,2007 . Emerging data suggest that systemically acting factors and alterations in cell-to-cell contact in stem niches impinge on stem cell aging (Boyle et al., 2007; Pan et al., 2007; Zhao et al., 2008) . The relative contribution of telomere dysfunction to these mechanisms of stem cell aging remains yet to be defined across different organ systems.
Outlook
In summary, current data suggest that self-renewing stem cells age because of cell intrinsic events and environmental alterations. Several lines of evidence suggest that the relative contributions of these routes of stem cell aging are highly context dependent. In mice, there are fundamental differences in aging wild type strains compared to mutant strains modeling the human situation of an age dependent accumulation of telomere dysfunction. Future studies focusing on model organisms and human aging should attempt to identify molecular mechanisms of stem cell aging relevant to human aging and disease. Such studies should ultimately lead to the identification of possible targets for future therapies aiming to improve regenerative reserve and organ maintenance in response to human aging and disease.
Table 1
Aging of hematopoietic stem cell is influenced by cell intrinsic and cell extrinsic mechanisms. In mice, telomere dysfunction changes the relative contribution of cell extrinsic and intrinsic mechanisms to HSC aging (Table 1) .
Stem cell aging Humans
Wildtype mice Telomere dysfunctional mice
HSC self renewal
Repopulation capacity
Skewing of hematopoiesis
Decreased CD34+ HSCs with human aging (Waterstrat, et.al., 2008.) . The contribution of cell intrinsic or extrinsic mechanisms is unknown.
